142 related articles for article (PubMed ID: 32796171)
1. A Proposed Staging System for Improved Prognostication of MDM2-amplified Liposarcoma.
Tucci JJ; Dashti NK; Cates JMM
Am J Surg Pathol; 2021 Jan; 45(1):101-107. PubMed ID: 32796171
[TBL] [Abstract][Full Text] [Related]
2. The AJCC 8th Edition Staging System for Soft Tissue Sarcoma of the Extremities or Trunk: A Cohort Study of the SEER Database.
Cates JMM
J Natl Compr Canc Netw; 2018 Feb; 16(2):144-152. PubMed ID: 29439175
[No Abstract] [Full Text] [Related]
3. Prognostic value of HMGA2, CDK4, and JUN amplification in well-differentiated and dedifferentiated liposarcomas.
Saâda-Bouzid E; Burel-Vandenbos F; Ranchère-Vince D; Birtwisle-Peyrottes I; Chetaille B; Bouvier C; Château MC; Peoc'h M; Battistella M; Bazin A; Gal J; Michiels JF; Coindre JM; Pedeutour F; Bianchini L
Mod Pathol; 2015 Nov; 28(11):1404-14. PubMed ID: 26336885
[TBL] [Abstract][Full Text] [Related]
4. Prognostic relevance of Fédération Nationale des Centres de Lutte Contre le Cancer grade and MDM2 amplification levels in dedifferentiated liposarcoma: a study of 50 cases.
Jour G; Gullet A; Liu M; Hoch BL
Mod Pathol; 2015 Jan; 28(1):37-47. PubMed ID: 25059573
[TBL] [Abstract][Full Text] [Related]
5. Are peripheral purely undifferentiated pleomorphic sarcomas with MDM2 amplification dedifferentiated liposarcomas?
Le Guellec S; Chibon F; Ouali M; Perot G; Decouvelaere AV; Robin YM; Larousserie F; Terrier P; Coindre JM; Neuville A
Am J Surg Pathol; 2014 Mar; 38(3):293-304. PubMed ID: 24525499
[TBL] [Abstract][Full Text] [Related]
6. Dedifferentiated liposarcomas with divergent myosarcomatous differentiation developed in the internal trunk: a study of 27 cases and comparison to conventional dedifferentiated liposarcomas and leiomyosarcomas.
Binh MB; Guillou L; Hostein I; Château MC; Collin F; Aurias A; Binh BN; Stoeckle E; Coindre JM
Am J Surg Pathol; 2007 Oct; 31(10):1557-66. PubMed ID: 17895758
[TBL] [Abstract][Full Text] [Related]
7. Subtype specific prognostic nomogram for patients with primary liposarcoma of the retroperitoneum, extremity, or trunk.
Dalal KM; Kattan MW; Antonescu CR; Brennan MF; Singer S
Ann Surg; 2006 Sep; 244(3):381-91. PubMed ID: 16926564
[TBL] [Abstract][Full Text] [Related]
8. Performance Analysis of the American Joint Committee on Cancer 8th Edition Staging System for Retroperitoneal Sarcoma and Development of a New Staging Algorithm for Sarcoma-Specific Survival.
Cates JMM
Ann Surg Oncol; 2017 Dec; 24(13):3880-3887. PubMed ID: 29058143
[TBL] [Abstract][Full Text] [Related]
9. Patterns of recurrence in extremity liposarcoma: implications for staging and follow-up.
Pearlstone DB; Pisters PW; Bold RJ; Feig BW; Hunt KK; Yasko AW; Patel S; Pollack A; Benjamin RS; Pollock RE
Cancer; 1999 Jan; 85(1):85-92. PubMed ID: 9921978
[TBL] [Abstract][Full Text] [Related]
10. Correlation of histological grade of dedifferentiation with clinical outcome in 55 patients with dedifferentiated liposarcomas.
Dantey K; Schoedel K; Yergiyev O; Bartlett D; Rao UNM
Hum Pathol; 2017 Aug; 66():86-92. PubMed ID: 28300575
[TBL] [Abstract][Full Text] [Related]
11. Risk Assessment of Visceral Sarcomas: A Comparative Study of 2698 Cases from the SEER Database.
Dashti NK; Cates JMM
Ann Surg Oncol; 2021 Oct; 28(11):6852-6860. PubMed ID: 33538930
[TBL] [Abstract][Full Text] [Related]
12. Dedifferentiated liposarcoma: a clinicopathological analysis of 155 cases with a proposal for an expanded definition of dedifferentiation.
Henricks WH; Chu YC; Goldblum JR; Weiss SW
Am J Surg Pathol; 1997 Mar; 21(3):271-81. PubMed ID: 9060596
[TBL] [Abstract][Full Text] [Related]
13. Fluorescence in situ hybridization for MDM2 gene amplification as a diagnostic tool in lipomatous neoplasms.
Weaver J; Downs-Kelly E; Goldblum JR; Turner S; Kulkarni S; Tubbs RR; Rubin BP; Skacel M
Mod Pathol; 2008 Aug; 21(8):943-9. PubMed ID: 18500263
[TBL] [Abstract][Full Text] [Related]
14. Simple staging system for osteosarcoma performs equivalently to the AJCC and MSTS systems.
Cates JMM
J Orthop Res; 2018 Oct; 36(10):2802-2808. PubMed ID: 29718558
[TBL] [Abstract][Full Text] [Related]
15. Intraperitoneal dedifferentiated liposarcoma showing MDM2 amplification: case report.
Grifasi C; Calogero A; Carlomagno N; Campione S; D'Armiento FP; Renda A
World J Surg Oncol; 2013 Nov; 11():305. PubMed ID: 24279301
[TBL] [Abstract][Full Text] [Related]
16. Predictors of survival after resection of retroperitoneal sarcoma: a population-based analysis and critical appraisal of the AJCC staging system.
Nathan H; Raut CP; Thornton K; Herman JM; Ahuja N; Schulick RD; Choti MA; Pawlik TM
Ann Surg; 2009 Dec; 250(6):970-6. PubMed ID: 19644351
[TBL] [Abstract][Full Text] [Related]
17. Staging soft tissue sarcoma of the head and neck: Evaluation of the AJCC 8th edition revised T classifications.
Cates JMM
Head Neck; 2019 Jul; 41(7):2359-2366. PubMed ID: 30779403
[TBL] [Abstract][Full Text] [Related]
18. Well-differentiated liposarcoma (atypical lipoma) of deep soft tissue of the extremities, retroperitoneum, and miscellaneous sites. A follow-up study of 92 cases with analysis of the incidence of "dedifferentiation".
Weiss SW; Rao VK
Am J Surg Pathol; 1992 Nov; 16(11):1051-8. PubMed ID: 1471725
[TBL] [Abstract][Full Text] [Related]
19. Modified staging system for extremity soft tissue sarcomas.
Ramanathan RC; A'Hern R; Fisher C; Thomas JM
Ann Surg Oncol; 1999; 6(1):57-69. PubMed ID: 10030416
[TBL] [Abstract][Full Text] [Related]
20. High level of CDK4 amplification is a poor prognostic factor in well-differentiated and dedifferentiated liposarcoma.
Lee SE; Kim YJ; Kwon MJ; Choi DI; Lee J; Cho J; Seo SW; Kim SJ; Shin YK; Choi YL
Histol Histopathol; 2014 Jan; 29(1):127-38. PubMed ID: 23852861
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
